Abstracts Developing and distributing a safe and effective SARS-CoV-2 (COVID-19) vaccine
has garnered immense global interest. Less than a year after COVID-19 was declared a …

Whether all children under 12 years of age should be vaccinated against COVID-19 remains
an ongoing debate. The relatively low risk posed by acute COVID-19 in children, and …

Enhancing vaccine uptake is a critical public health challenge. Overcoming vaccine
hesitancy, and failure to follow through on vaccination intentions requires effective …

There is great disparity in the way we think about and address different sources of
environmental infection. Governments have for decades promulgated a large amount of …

We evaluate the impact of government-mandated proof of vaccination requirements for
access to public venues and non-essential businesses on COVID-19 vaccine uptake. We …

Many months after COVID‐19 vaccines were first authorised for public use, still limited
supplies could only partially reduce the devastating loss of life and economic costs caused …

As the twenty-first century unfolds, nanotechnology is no longer just a buzzword in the field
of materials science, but rather a tangible reality. This is evident from the surging number of …

Healthcare supply chains face a couple of challenges in keeping vaccines safe from the
phase of production to the injection. Therefore, it is necessary to create a robust vaccine …

This minireview addresses problems of financing the vaccine development, regulatory
questions, the ethics and efficacy of vaccine prioritization strategies and the coverage of …

Vaccinating the world's population quickly in a pandemic has enormous health and
economic benefits. We analyze the problem faced by governments in determining the scale …